Cite
HARVARD Citation
Nazareth, N. et al. (n.d.). Infliximab therapy increases the frequency of circulating CD16+ monocytes and modifies macrophage cytokine response to bacterial infection. Clinical and experimental immunology. pp. 703-711. [Online].